The disclosure features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers.
-
Paragraph 1483-1484
(2021/05/07)
More Articles about upstream products of 1092351-92-2